AmCad BioMed Corporation (TPEX:4188)

AmCad BioMed Revenue

AmCad BioMed had revenue of 10.43M TWD in the quarter ending September 30, 2025, a decrease of -0.80%. This brings the company's revenue in the last twelve months to 43.51M, down -25.47% year-over-year. In the year 2024, AmCad BioMed had annual revenue of 53.11M, down -18.62%.

• Revenue (ttm): 43.51M
• Revenue Growth: -25.47%
• P/S Ratio: 21.25
• Revenue / Employee: 1.28M
• Employees: 34
• Market Cap: 924.66M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	53.11M	-12.15M	-18.62%
Dec 31, 2023	65.26M	3.63M	5.88%
Dec 31, 2022	61.63M	-24.16M	-28.16%
Dec 31, 2021	85.79M	21.85M	34.17%
Dec 31, 2020	63.94M	-20.15M	-23.96%